Latest filing published 01 Oct 2026 for Renalytix plc, €82k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Harwood Capital LLP*: trading record in brief
Harwood Capital LLP* appears in our data through filings on Renalytix plc shares, published by SEC (Form 4). In total, 4 filings cover trades dated from 7 October 2024 to 29 September 2026.
Both buying and selling appear: 1 purchase worth €82k, against 2 sales worth €880k. On balance, insiders were net sellers of €798k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2026 to date brings 1 purchase and 1 sale.
The latest filing, published on 1 October 2026, reports an open-market sale of €82k in Renalytix plc. The clock since the last published purchase (1 October 2026) now reads 39 days. The median gap between a trade and its publication by SEC (Form 4) is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Harwood Capital LLP*
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,166,667 shares@ £0.060.016% mcap1.3% of flowLondon Stock Exchange, AIMFCA-NSM:35448326-dfcf-4be4-ae36-773d1f4f79b9
- 1,166,667 shares@ £0.06London Stock Exchange, AIMISIN GB00BYWL4Y04RNS:9805076Canonical exit: 28 Dec 2026 (T+90)
- 83,696 shares@ £8.0012.9% of flowLondon Stock Exchange, AIMRNS:5385335-0
- 500,000 shares@ £9.0087.1% of flowOff marketRNS:5385335-1Canonical exit: 6 Jan 2025 (T+90)
4 of 4 declarations